What Have Been Your Greatest Lessons Learned?
Source: Life Science Leader
MY GREATEST EDUCATION CAME NOT IN ACADEMIA, but instead at the hands of investors and colleagues.
The ability to see a scientific advance, find the right application, and take it to commercialization is 90% of the work (not the inventing of it).
Being a key opinion leader doesn’t mean you are right; you still need data and an open mind.
You always need money.
People are not always honest about their motivations. If you have questions, ask for the answers and correlate motives and incentives.
Newfound authority or influence must be used with wisdom, which, if you don’t have, you need to find or hire.
During Biotech Showcase Digital, registered conference participants will be able to watch a pre-recorded presentation by BioEclipse. Also, Dr. Contag will host virtual one-on-one meetings with registered investors and pharmaceutical and biotechnology companies via the conference s networking and scheduling platform, partneringONE®, to discuss BioEclipse s business and highlight recent corporate achievements, as well as anticipated milestones in the clinical program for CRX100. BioEclipse has initiated an open-label, Phase 1 dose-escalation study to evaluate the safety, tolerability, and pharmacokinetic (PK) properties of CRX100 in advanced solid tumors that do not respond to standard of care, including triple-negative breast cancer, colorectal cancer, hepatocellular carcinoma, osteosarcoma, epithelial ovarian cancer, and gastric cancer.